Summary
The pharmacokinetics of amikacin was studied in 17 hospitalized patients with normal renal function (creatinine clearance greater than 90 ml/min), after the administration of a single dose of 7.5 mg/kg body weight. In 10 patients the antibiotic was administered intravenously and in the other 7 it was injected intramuscularly. After i. v. administration, the antibiotic followed an open two-compartment kinetic model, and after i. m. administration it followed a single compartment kinetic model. The route of administration did not significantly modify the pharmacokinetic parameters of amikacin. On the basis of the pharmacokinetic parameters thus established, an intravenous infusion for therapeutic use should have an administration rate of 2.5 [mg/kg/h] and a duration of 6 h.
Similar content being viewed by others
References
Kawaguchi H (1976) Discovery, chemistry and activity of amikacin. J Infect Dis 134 (Suppl): S242-S247
Saunders L, Natunen T (1972) A statistical approach to pharmacokinetics calculations. J Pharm Pharmacol 24 (Suppl): 94P-99P
Wagner JG, Nelson E (1963) Percent absorbed time plots derived from blood level and or urinary excretion data. J Pharm Sci 52: 610–611
Thompson WL (1978) Nephrotoxicité de la gentamicine et de la tobramycine chez le chien. Comparaison après perfusion continu ou injection intraveineuse unique. Nouv Press Med 42: 3830–3832
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lanao, J.M., Dominguez-Gil, A., Tabernero, J.M. et al. Influence of the route of administration on the pharmacokinetics of amikacin. Eur J Clin Pharmacol 19, 367–370 (1981). https://doi.org/10.1007/BF00544588
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00544588